1. Home
  2. TAK vs BSBR Comparison

TAK vs BSBR Comparison

Compare TAK & BSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • BSBR
  • Stock Information
  • Founded
  • TAK 1781
  • BSBR 1985
  • Country
  • TAK Japan
  • BSBR Brazil
  • Employees
  • TAK N/A
  • BSBR N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • BSBR Commercial Banks
  • Sector
  • TAK Health Care
  • BSBR Finance
  • Exchange
  • TAK Nasdaq
  • BSBR Nasdaq
  • Market Cap
  • TAK 45.8B
  • BSBR 39.9B
  • IPO Year
  • TAK N/A
  • BSBR 2009
  • Fundamental
  • Price
  • TAK $14.68
  • BSBR $5.04
  • Analyst Decision
  • TAK
  • BSBR Strong Buy
  • Analyst Count
  • TAK 0
  • BSBR 2
  • Target Price
  • TAK N/A
  • BSBR $6.00
  • AVG Volume (30 Days)
  • TAK 2.3M
  • BSBR 455.6K
  • Earning Date
  • TAK 07-30-2025
  • BSBR 07-30-2025
  • Dividend Yield
  • TAK 3.70%
  • BSBR 4.08%
  • EPS Growth
  • TAK N/A
  • BSBR 41.36
  • EPS
  • TAK 0.45
  • BSBR 0.31
  • Revenue
  • TAK $30,595,075,281.00
  • BSBR $8,353,642,429.00
  • Revenue This Year
  • TAK $1.01
  • BSBR N/A
  • Revenue Next Year
  • TAK $1.04
  • BSBR N/A
  • P/E Ratio
  • TAK $65.09
  • BSBR $7.92
  • Revenue Growth
  • TAK 7.45
  • BSBR 17.11
  • 52 Week Low
  • TAK $12.80
  • BSBR $3.75
  • 52 Week High
  • TAK $15.53
  • BSBR $5.77
  • Technical
  • Relative Strength Index (RSI)
  • TAK 41.31
  • BSBR 36.50
  • Support Level
  • TAK $14.93
  • BSBR $5.37
  • Resistance Level
  • TAK $15.14
  • BSBR $5.50
  • Average True Range (ATR)
  • TAK 0.15
  • BSBR 0.10
  • MACD
  • TAK -0.06
  • BSBR -0.05
  • Stochastic Oscillator
  • TAK 11.86
  • BSBR 2.83

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About BSBR Banco Santander Brasil SA each representing one unit

Banco Santander (Brasil) SA is part of Santander Group, a Spanish bank. It operates across two segments; the Commercial Banking segment, catering to both individual and corporate client and the Global Wholesale Banking segment, which encompasses Investment Banking and Markets operations, including the Treasury and Equity Business Departments. The bank generates majority of its revenue from the Commercial Banking segment and has operations in Brazil and internationally.

Share on Social Networks: